Exploring Mastocytosis & Kinases as the Basis of the History of Masitinib in ALS Mechanism of Action & Reviewing Clinical Results

Time: 3:30 pm
day: Day Two


  • Investigating the mechanism of action of masitinib in ALS with the SOD1 rat model
  • Assessing Masitinib to block the activity of tyrosine kinases and decrease nerve cell dysfunction in ALS
  • Evaluating clinical results of Masitinib in combination therapy